Dimitri Daldegan‐Bueno
- Clinical Psychology top 10%
- Psychedelics and Drug Studies 18
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 17
- Toxicology top 10%
-
- Biochemical Analysis and Sensing Techniques 7
-
- Substance Abuse Treatment and Outcomes 10
-
- Chemical synthesis and alkaloids 5
-
- Prenatal Substance Exposure Effects 5
-
- Homelessness and Social Issues 5
-
- Neurotransmitter Receptor Influence on Behavior 4
Dimitri Daldegan‐Bueno
33 papers receiving 350 citations
Peers
Comparison fields: 5 of 79
- Clinical Psychology 185
- Pharmacology 139
- Toxicology 20
- Biological Psychiatry 11
- Nutrition and Dietetics 64
Countries citing papers authored by Dimitri Daldegan‐Bueno
This map shows the geographic impact of Dimitri Daldegan‐Bueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Daldegan‐Bueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Daldegan‐Bueno more than expected).
Fields of papers citing papers by Dimitri Daldegan‐Bueno
This network shows the impact of papers produced by Dimitri Daldegan‐Bueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Daldegan‐Bueno. The network helps show where Dimitri Daldegan‐Bueno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dimitri Daldegan‐Bueno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 9 | |
| 9 | 2022 | 45 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 40 | |
| 14 | 2022 | 23 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 13 | |
| 18 | 2020 | 2 | |
| 19 | 2020 | 4 | |
| 20 | 2020 | 16 |
About Dimitri Daldegan‐Bueno
Dimitri Daldegan‐Bueno is a scholar working on Toxicology, Pharmacology and Clinical Psychology, having authored 34 papers that have together received 359 indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (18 papers), Cannabis and Cannabinoid Research (17 papers), Substance Abuse Treatment and Outcomes (10 papers), Biochemical Analysis and Sensing Techniques (7 papers), Chemical synthesis and alkaloids (5 papers), Prenatal Substance Exposure Effects (5 papers), Homelessness and Social Issues (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). The work is most often cited by research in Clinical Psychology (185 citations), Pharmacology (139 citations) and Toxicology (20 citations). Dimitri Daldegan‐Bueno has collaborated with scholars based in Brazil, New Zealand and Canada. Frequent co-authors include Benedikt Fischer, Lucas Oliveira Maia, Luís Fernando Tófoli, Maria Gabriela Menezes Oliveira, Altay Alves Lino de Souza, Didier Jutras‐Aswad, Dráulio Barros de Araújo, Joseph M. Boden, Peter Reuter and Tessa Robinson.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.